BIO logo

Bio-Rad Laboratories (BIO)

Profile

Full Name

Bio-Rad Laboratories, Inc.

Ticker Symbol

BIO

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 27, 1980

Indexes

Not included

Website

http://www.bio-rad.com

Employees

7700

Key Details

Price

$236.74(+2.04%)

Market cap

$6.44B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.57B(-3.92% YoY)

Annual EPS

-$65.36(-199.54% YoY)

PE ratio

-

Next earnings date

Aug 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $236.74
    BIO price is $236.74

    30-Day Relative Volume

    3.60
    BIO 30-day relative volume is 3.60

    Price Performance

    Price Most recent change

    +2.04%
    BIO price was up +2.04% on Jun 20, 2025

    Price YTD change

    -27.94%
    BIO price is down -27.94% since January 1st

    Price 1-year change

    -17.11%
    BIO price is down -17.11% year-on-year

    Price 3-year change

    -48.94%
    BIO price is down -48.94% over the past 3 years

    Price Range

    Price All-time high

    $832.70
    BIO price is currently -71.57% below its historical high of $832.70

    Price 3-year low

    $211.43
    BIO price is currently +11.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $6.44B
    BIO market capitalization is $6.44 billion

    Market cap 3-year change

    -53.2%
    BIO market capitalization is down -53.2% over the past 3 years

    Market cap All-time high

    $24.59B
    BIO market capitalization is currently -73.80% below its historical high of $24.59 billion

    Market cap sector rank

    90.36%
    BIO market capitalization is higher than 90.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -4.6%
    BIO shares outstanding is down -4.6% year-on-year

    Shares Outstanding 3-Year Change

    -8.33%
    BIO shares outstanding is down -8.33% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.97
    BIO beta is 0.97

    200-day SMA

    $297.89
    BIO price is currently -20.53% below its 200-day simple moving average

    50-day SMA

    $236.35
    BIO price is currently +0.16% above its 50-day simple moving average

    RSI

    54.91
    BIO 14-day relative strength index is 54.91

    Volume

    3.60
    BIO 30-day relative volume is 3.60

    ATR

    $7.25
    BIO average true range is $7.25

    10-day Historical Volatility

    25.13%
    BIO 10-day historical volatility is 25.13%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.57B
    BIO annual revenue is $2.57 billion

    Revenue Analysts estimate

    $2.52B
    BIO annual revenue is currently +1.80% higher than the consensus analysts' forecast

    Revenue 1-year change

    -3.92%
    BIO annual revenue is down -3.92% year-on-year

    Revenue Sector rank

    86.89%
    BIO annual revenue is higher than 86.89% of companies in Healthcare sector

    EPS

    EPS

    -$65.36
    BIO annual earnings per share is -$65.36

    EPS Analysts estimate

    $8.51
    BIO annual earnings per share is currently -867.67% lower than the consensus analysts' forecast

    EPS 1-year change

    -199.54%
    BIO annual earnings per share is down -199.54% year-on-year

    EPS Sector rank

    3.37%
    BIO annual earnings per share is higher than 3.37% of companies in Healthcare sector

    Profit

    Gross profit

    $1.38B
    BIO annual gross profit is $1.38 billion

    Gross margin

    53.73%
    BIO annual gross profit margin is 53.73%

    Operating profit

    $269.00M
    BIO annual operating income is $269.00 million

    Operating margin

    10.48%
    BIO annual operating profit margin is 10.48%

    Net income

    -$1.84B
    BIO annual net profit is -$1.84 billion

    Net margin

    -71.86%
    BIO annual net profit margin is -71.86%

    Expenses

    Total expenses

    $2.30B
    BIO annual total expenses is $2.30 billion

    Operating expenses

    $1.11B
    BIO annual total operating expenses is $1.11 billion

    Cost of goods sold

    $1.19B
    BIO annual cost of goods sold is $1.19 billion

    Selling, general & administrative expenses

    $814.00M
    BIO annual SGA is $814.00 million

    Depreciation and amortization

    $151.60M
    BIO annual depreciation & amortization is $151.60 million

    Interest expense

    $48.90M
    BIO annual interest expense is $48.90 million

    Income tax

    -$498.30M
    BIO annual income tax is -$498.30 million

    EBIT & EBITDA

    EBIT

    -$2.29B
    BIO annual earnings before interest & taxes is -$2.29 billion

    EBITDA

    -$2.14B
    BIO annual EBITDA is -$2.14 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $9.36B
    BIO annual total assets is $9.36 billion

    Non current assets

    $6.33B
    BIO annual long term assets is $6.33 billion

    Current assets

    $3.03B
    BIO annual total current assets is $3.03 billion

    Cash and cash equivalents

    $488.10M
    BIO annual cash & cash equivalents is $488.10 million

    Accounts receivable

    $452.50M
    BIO annual accounts receivable is $452.50 million

    Inventory

    $760.00M
    BIO annual inventory is $760.00 million

    Liabilities

    Total liabilities

    $2.79B
    BIO annual total liabilities is $2.79 billion

    Long term liabilities

    $2.33B
    BIO annual total long term liabilities is $2.33 billion

    Current liabilities

    $467.80M
    BIO annual total current liabilities is $467.80 million

    Accounts payable

    $122.30M
    BIO annual accounts payable is $122.30 million

    Debt

    Total debt

    $1.37B
    BIO annual total debt is $1.37 billion

    Total debt 1-year change

    -2.19%
    BIO annual total debt is down -2.19% year-on-year

    Long term debt

    $1.33B
    BIO annual long term debt is $1.33 billion

    Short term debt

    $42.90M
    BIO annual short term debt is $42.90 million

    Equity & Capital

    Shareholders equity

    $6.57B
    BIO annual stockholders equity is $6.57 billion

    Book value

    $6.57B
    BIO annual book value is $6.57 billion

    Retained earnings

    $7.42B
    BIO annual retained earnings is $7.42 billion

    Working capital

    $2.56B
    BIO annual working capital is $2.56 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $455.20M
    BIO annual cash flow from operations is $455.20 million

    Cash from operations 1-year change

    +21.42%
    BIO annual cash flow from operations is up +21.42% year-on-year

    Cash from investing

    -$160.20M
    BIO annual cash flow from investing activities is -$160.20 million

    Cash from investing 1-year change

    -893.07%
    BIO annual cash flow from investing activities is down -893.07% year-on-year

    Cash from financing

    -$218.80M
    BIO annual cash flow from financing activities is -$218.80 million

    Cash from financing 1-year change

    +48.59%
    BIO annual cash flow from financing activities is up +48.59% year-on-year

    CAPEX

    CAPEX

    $189.00M
    BIO annual capital expenditures is $189.00 million

    CAPEX 1-year change

    +20.61%
    BIO annual capital expenditures is up +20.61% year-on-year

    Free Cash Flow

    Free cash flow

    $266.20M
    BIO annual free cash flow is $266.20 million

    Free cash flow 1-year change

    +22%
    BIO annual free cash flow is up +22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    53.73%
    BIO annual gross profit margin is 53.73%

    Operating margin

    10.48%
    BIO annual operating profit margin is 10.48%

    Net margin

    -71.86%
    BIO annual net profit margin is -71.86%

    ROA & ROE

    ROA

    -17.03%
    BIO annual return on assets is -17.03%

    ROE

    -24.09%
    BIO annual return on equity is -24.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.96
    BIO price to book ratio is 0.96

    PB ratio Sector rank

    39.39%
    BIO price to book ratio is higher than 39.39% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.54
    BIO price to sales ratio is 2.54

    PS ratio Sector rank

    47.63%
    BIO price to sales ratio is higher than 47.63% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $7.29B
    BIO enterprise value is $7.29 billion

    Enterprise value Sector rank

    90.11%
    BIO enterprise value is higher than 90.11% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.86
    BIO EV/EBITDA is -2.86

    EV/EBITDA Sector rank

    31.57%
    BIO EV/EBITDA is higher than 31.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    6.48
    BIO annual current ratio is 6.48

    Quick ratio

    4.85
    BIO annual quick ratio is 4.85

    Leverage

    Debt to equity

    0.18
    BIO annual debt to equity ratio is 0.18

    Interest coverage ratio

    -46.90
    BIO annual interest coverage ratio is -46.90

    Risk & Stability

    Piotroski F-Score

    5
    BIO piotroski f-score is 5

    Altman Z-Score

    2.29
    BIO altman z-score is 2.29

    Analyst ratings

    Recent major analysts updates

    Jun 9, 25 Wells Fargo
    Equal-Weight
    May 2, 25 UBS
    Buy
    May 2, 25 RBC Capital
    Outperform
    May 2, 25 Citigroup
    Buy
    Apr 17, 25 Wells Fargo
    Equal-Weight
    Feb 12, 25 Wells Fargo
    Equal-Weight
    Jan 14, 25 RBC Capital
    Outperform
    Dec 9, 24 RBC Capital
    Outperform
    Oct 31, 24 RBC Capital
    Outperform
    Oct 31, 24 Citigroup
    Buy

    Institutional Ownership

    Screeners with BIO included

    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Companies with buyback
    Best performing stocks last 15 years
    Ex Dividend dates calendar
    • What is the ticker symbol for Bio-Rad Laboratories?
    • Does Bio-Rad Laboratories pay dividends?
    • What sector is Bio-Rad Laboratories in?
    • What industry is Bio-Rad Laboratories in?
    • What country is Bio-Rad Laboratories based in?
    • When did Bio-Rad Laboratories go public?
    • Is Bio-Rad Laboratories in the S&P 500?
    • Is Bio-Rad Laboratories in the NASDAQ 100?
    • Is Bio-Rad Laboratories in the Dow Jones?
    • When was Bio-Rad Laboratories's last earnings report?
    • When does Bio-Rad Laboratories report earnings?
    • Should I buy Bio-Rad Laboratories stock now?

    What is the ticker symbol for Bio-Rad Laboratories?

    The ticker symbol for Bio-Rad Laboratories is NYSE:BIO

    Does Bio-Rad Laboratories pay dividends?

    No, Bio-Rad Laboratories does not pay dividends

    What sector is Bio-Rad Laboratories in?

    Bio-Rad Laboratories is in the Healthcare sector

    What industry is Bio-Rad Laboratories in?

    Bio-Rad Laboratories is in the Medical Devices industry

    What country is Bio-Rad Laboratories based in?

    Bio-Rad Laboratories is headquartered in United States

    When did Bio-Rad Laboratories go public?

    Bio-Rad Laboratories's initial public offering (IPO) was on February 27, 1980

    Is Bio-Rad Laboratories in the S&P 500?

    No, Bio-Rad Laboratories is not included in the S&P 500 index

    Is Bio-Rad Laboratories in the NASDAQ 100?

    No, Bio-Rad Laboratories is not included in the NASDAQ 100 index

    Is Bio-Rad Laboratories in the Dow Jones?

    No, Bio-Rad Laboratories is not included in the Dow Jones index

    When was Bio-Rad Laboratories's last earnings report?

    Bio-Rad Laboratories's most recent earnings report was on May 1, 2025

    When does Bio-Rad Laboratories report earnings?

    The next expected earnings date for Bio-Rad Laboratories is Aug 1, 2025

    Should I buy Bio-Rad Laboratories stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page